Ardea Partners LP and Citi acted as placement agents on the transaction, and Allen & Overy LLP
served as legal counsel to Babylon. Shearman & Sterling LLP served as legal counsel to AlbaCore.
About Babylon
Babylon is a world leading, digital-first, value-based care company whose mission is to make high-quality healthcare accessible and affordable for everyone on
Earth.
Babylon is re-engineering healthcare, shifting the focus from sick care to preventative healthcare so that
patients experience better health, and reduced costs. This is achieved by leveraging a highly scalable, digital-first platform combined with high quality, virtual clinical operations to provide integrated, personalized healthcare. We endeavor to
support patients health needs, all from their devices, with the aim to promote longer and healthier lives. When sick, Babylon provides assistance to navigate the health system, connecting patients digitally to the right clinician 24/7, at no
additional cost.
Founded in 2013, we have since delivered millions of clinical consultations and AI interactions, with c.2m clinical consultations and
c.3.9m AI interactions in 2020 alone. We work with governments, health providers and insurers across the globe, and support healthcare facilities from small local practices to large hospitals. For more information, please visit
www.babylonhealth.com/us.
About AlbaCore Capital Group
AlbaCore is one of Europes leading specialist credit investors focusing on public and private corporate credit markets. The senior investment team has
been investing with this hybrid strategy for over a decade. Founded in 2016, AlbaCore has invested over $17bn for global pension funds, sovereign wealth funds, consultants, insurance companies, family offices and endowments.
AlbaCore is focused on consistently outperforming the market while protecting investor capital. The credit selection process is based on fundamental research
with a focus on capital preservation, ESG factors and risk-adjusted returns.
Headquartered in London and with offices in New York and Dublin, AlbaCore
has a partnership approach with values at the center of the AlbaCore community. www.AlbaCoreCapitalGroup.com.
About Alkuri Global Acquisition Corp.
Alkuri Global Acquisition Corp. (NASDAQ: KURI, KURIU and KURIW) is a blank check company formed for the purpose of effecting a merger, stock exchange,
asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. While Alkuri Global Acquisition Corp. may pursue a business combination in any industry, the company intends to favor
next-generation technology businesses led by visionary founders and teams leveraging data and artificial intelligence in the areas of Consumer Internet and Marketplaces, Healthtech, Fintech and Mobility.
Additional Information and Where to Find It
In
connection with the proposed business combination between Alkuri Global Acquisition Corporation (Alkuri Global) and Babylon Holdings Limited (Babylon) and the other parties to the Merger Agreement dated June 3, 2021 (the
Merger Agreement), Babylon filed a registration statement on Form F-4 (File No. 333-257694) (the Registration Statement) with the U.S.
Securities and Exchange Commission (the SEC), which was declared effective on September 30, 2021, with respect to Babylons securities to be issued in connection with the proposed business combination, and Alkuri Global filed a
definitive proxy statement on September 30, 2021 in connection with Alkuri Globals solicitation of proxies for the vote by Alkuri Globals stockholders in connection with the proposed business combination and other matters as
described in the proxy statement, as well as the prospectus relating to the offer of the securities to be issued to Alkuri Globals stockholders in connection with the completion of the business combination. Alkuri Global has mailed the
definitive proxy statement and other relevant documents to its stockholders as of the record date established for voting on the proposed business combination.